Free Trial
ETR:BIO

Biotest Aktiengesellschaft (BIO) Stock Price, News & Analysis

Biotest Aktiengesellschaft logo
€40.20 0.00 (0.00%)
As of 06/10/2025

About Biotest Aktiengesellschaft Stock (ETR:BIO)

Key Stats

Today's Range
€40.20
€40.20
50-Day Range
€40.20
€43.00
52-Week Range
€40.40
€43.40
Volume
19 shs
Average Volume
1,927 shs
Market Capitalization
€795.56 million
P/E Ratio
9.69
Dividend Yield
0.10%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotest Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BIO Stock News Headlines

BIOTEST AG VZ
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Biotest Aktiengesellschaft (BIO.DE)
See More Headlines

BIO Stock Analysis - Frequently Asked Questions

Biotest Aktiengesellschaft's stock was trading at €41.20 at the start of the year. Since then, BIO stock has decreased by 2.4% and is now trading at €40.20.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotest Aktiengesellschaft investors own include GSK (GSK), Invitae (NVTA), Adaptive Biotechnologies (ADPT), ADMA Biologics (ADMA), Analog Devices (ADI), Adaptimmune Therapeutics (ADAP) and Axcelis Technologies (ACLS).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Biotechnology
Sub-Industry
Measuring And Control Equipment
Current Symbol
ETR:BIO
CIK
N/A
Fax
N/A
Employees
8,200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
€4.15
Trailing P/E Ratio
9.69
Forward P/E Ratio
335.00
P/E Growth
N/A
Net Income
€164.40 million
Net Margins
9.69%
Pretax Margin
N/A
Return on Equity
13.11%
Return on Assets
8.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.54
Quick Ratio
1.66

Sales & Book Value

Annual Sales
€781.30 million
Price / Sales
1.02
Cash Flow
€1.30 per share
Price / Cash Flow
31.04
Book Value
€14.18 per share
Price / Book
2.83

Miscellaneous

Outstanding Shares
19,790,000
Free Float
N/A
Market Cap
€795.56 million
Optionable
Not Optionable
Beta
0.24
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ETR:BIO) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners